The patient voice in ICER value assessments: an interview with Yvette Venable

Written by YVETTE VENABLE (INSTITUTE FOR CLINICAL AND ECONOMIC REVIEW)

In this feature, following participating in an Issue Panel at the International Society for Pharmacoeconomics and Outcomes Research’s 2021 virtual annual meeting (Virtual ISPOR 2021; 17–20 May), Yvette Venable (Institute for Clinical and Economic Review; ICER, MA, USA) discusses how ICER has engaged with patient organizations and incorporated the patient voice in its drug value assessments, and the importance of this. Please could you introduce yourself, your organization(s) and provide a brief summary of your career to date? I am the Vice President of Patient Engagement at ICER. I am the first person to hold this position, which ICER instituted...

To view this content, please register now for access

It's completely free